BioSpace News Archive

Press Releases

Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease

August 12, 2025
·
8 min read
Press Releases

Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update

August 12, 2025
·
12 min read
Press Releases

Tecan reports solid financial results for the first half of 2025 and confirms its outlook for full year 2025

August 12, 2025
·
15 min read
Press Releases

iPETcertum™ by Claritas, Developed with Cutting-Edge Technology for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scans, Receives FDA Clearance

August 12, 2025
·
3 min read
Press Releases

Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering

August 12, 2025
·
11 min read
Press Releases

Fosun Pharma’s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

August 12, 2025
·
4 min read
Press Releases

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025

August 12, 2025
·
20 min read
Press Releases

Neurogene Reports Second Quarter 2025 Financial Results and Highlights Recent Updates

August 12, 2025
·
10 min read
Press Releases

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

August 12, 2025
·
4 min read
Press Releases

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 11, 2025

August 12, 2025
·
1 min read